Your browser doesn't support javascript.
loading
Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.
Roe, Matthew T; Cyr, Derek D; Eckart, Debra; Schulte, Phillip J; Morse, Michael A; Blackwell, Kimberly L; Ready, Neal E; Zafar, S Yousuf; Beaven, Anne W; Strickler, John H; Onken, Jane E; Winters, Kenneth J; Houterloot, Lisa; Zamoryakhin, Dmitry; Wiviott, Stephen D; White, Harvey D; Prabhakaran, Dorairaj; Fox, Keith A A; Armstrong, Paul W; Ohman, E Magnus.
Afiliación
  • Roe MT; Duke Clinical Research Institute, 2400 Pratt Street, Rm 7035, Durham, NC 27705, USA Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA matthew.roe@duke.edu.
  • Cyr DD; Duke Clinical Research Institute, 2400 Pratt Street, Rm 7035, Durham, NC 27705, USA.
  • Eckart D; Duke Clinical Research Institute, 2400 Pratt Street, Rm 7035, Durham, NC 27705, USA.
  • Schulte PJ; Duke Clinical Research Institute, 2400 Pratt Street, Rm 7035, Durham, NC 27705, USA.
  • Morse MA; Division of Medicine - Oncology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Blackwell KL; Division of Medicine - Oncology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Ready NE; Division of Medicine - Oncology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Zafar SY; Division of Medicine - Oncology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Beaven AW; Division of Medicine - Oncology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Strickler JH; Division of Medicine - Oncology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Onken JE; Division of Gastroenterology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Winters KJ; Eli Lilly and Company, Indianapolis, IN, USA.
  • Houterloot L; Eli Lilly and Company, Indianapolis, IN, USA.
  • Zamoryakhin D; Daiichi Sankyo Development Ltd., London, UK.
  • Wiviott SD; Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA.
  • White HD; Auckland City Hospital, Green Lane Cardiovascular Service, Auckland, New Zealand.
  • Prabhakaran D; Centre for Chronic Disease Control and Public Health Foundation of India, New Delhi, India.
  • Fox KA; British Heart Foundation Centre for Cardiovascular Sciences, University of Edinburgh, Edinburgh, UK.
  • Armstrong PW; Division of Cardiology, University of Alberta, Edmonton, AB, Canada.
  • Ohman EM; Duke Clinical Research Institute, 2400 Pratt Street, Rm 7035, Durham, NC 27705, USA Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
Eur Heart J ; 37(4): 412-22, 2016 Jan 21.
Article en En | MEDLINE | ID: mdl-26637834

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ticlopidina / Inhibidores de Agregación Plaquetaria / Síndrome Coronario Agudo / Clorhidrato de Prasugrel / Infarto del Miocardio sin Elevación del ST / Neoplasias Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Eur Heart J Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ticlopidina / Inhibidores de Agregación Plaquetaria / Síndrome Coronario Agudo / Clorhidrato de Prasugrel / Infarto del Miocardio sin Elevación del ST / Neoplasias Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Eur Heart J Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido